Clinical Trial Update: Study of the Absolute Oral Bioavailability of Dapagliflozin in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study assessing the absolute oral bioavailability of dapagliflozin in healthy subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• FARXIGA (dapagliflozin)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED